On March 15, 2023 Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body, announced today that it will host a conference call and webcast to provide a business and clinical update on Tuesday, March 21, 2023 at 4:30 p.m. EDT (Press release, Cue Biopharma, MAR 15, 2023, View Source [SID1234628832]). Live and archived versions of the event can be accessed via the Company’s website.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Members of the Cue Biopharma executive management team will provide a clinical update from the Company’s ongoing trials evaluating its lead interleukin 2 (IL-2)-based biologic, CUE-101, as a monotherapy and in combination with pembrolizumab (KEYTRUDA) for patients with recurrent/metastatic HPV+ head and neck cancer. Management will also provide updates on CUE-102, the Company’s second IL-2-based clinical drug candidate for the treatment of Wilms’ Tumor 1 (WT1) expressing cancers, its strategic objectives and anticipated milestones including Cue Biopharma’s most recent partnership with Ono Pharmaceutical to advance the Company’s lead autoimmune disease asset, CUE-401, toward the clinic.
Webcast Details
Tuesday, March 21 at 4:30 p.m. EDT
Investors: 1-877-407-9208
International: 1-201-493-6784
Conference ID: 13736864
Request a return call via the Call me link: View Source;passcode=13736864&h=true&info=company-email&r=true&B=6
Participants can use the guest dial-in numbers above and be answered by an operator or click the Call me link for instant telephone access. The link will be active 15 minutes prior to the scheduled start time.
Webcast: View Source;tp_key=6f69873566